Yu-Ting Chiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu-Ting Chiang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Yu Tsai
Department of Otolaryngology, National Taiwan University College of Medicine, Taipei 100225, Taiwan
3 shared publications - Chen-Chi Wu
Department of Otolaryngology, National Taiwan University Hospital, Taipei 100225, Taiwan
2 shared publications - Chuan-Jen Hsu
Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan
2 shared publications - Jacob Shujui Hsu
Graduate Institute of Medical Genomics and Proteomics, College of Medicine National Taiwan University Taipei Taiwan
2 shared publications Pei-Hsuan Lin
Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
2 shared publicationsPei-Lung Chen
Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
2 shared publications
Latest Publications
- Open Access
- 31 May 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (2) , 152-161
Screening for Hearing Impairment in Newborns Using Targeted Genomic Sequencing: A Large Pilot Cohort Study
Objectives. State-run newborn hearing screening (NBHS) programs have limitations in identifying children with mild or late-onset sensorineural hearing impairment (SNHI). Given that over 50% of pediatric SNHI cases are linked to genetic causes, the increasing accessibility of high-throughput, low-cost genomic sequencing may help address these shortcomings. This study investigates the feasibility of integrating a next-generation sequencing (NGS)-based genomic screening protocol into conventional NBHS and examines its potential benefits and challenges.Methods. A total of 8,261 newborns underwent simultaneous NBHS and NGS-based genomic screening targeting 46 deafness genes in this prospective study. The subjects’ genotypes were determined, and those with conclusive genetic diagnoses received audiological assessments.Results. Conclusive genetic diagnoses were confirmed in 164 subjects, with 112 carrying variants in GJB2 and MTRNR1 and 52 carrying variants in other deafness genes. Notably, 126 of these subjects passed the NBHS, suggesting that an additional 1.5% (126/8,261) of children at risk for SNHI, who would have been missed by conventional physiological screening, can be identified through targeted genomic screening in the general population. Furthermore, one subject’s father, who carried a COL4A5 variant, and three paternal relatives of another subject carrying an EDNRB variant (previously undiagnosed) were identified with Alport and Waardenburg syndromes, respectively, underscoring the familial benefits of this approach.Conclusion. Targeted genomic sequencing in newborns may serve as a valuable complement to conventional NBHS by identifying children at risk for SNHI and enabling early diagnosis in families with non-syndromic mimics.
- 31 May 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (2) , 152-161
Open AccessScreening for Hearing Impairment in Newborns Using Targeted Genomic Sequencing: A Large Pilot Cohort Study
Objectives. State-run newborn hearing screening (NBHS) programs have limitations in identifying children with mild or late-onset sensorineural hearing impairment (SNHI). Given that over 50% of pediatric SNHI cases are linked to genetic causes, the increasing accessibility of high-throughput, low-cost genomic sequencing may help address these shortcomings. This study investigates the feasibility of integrating a next-generation sequencing (NGS)-based genomic screening protocol into conventional NBHS and examines its potential benefits and challenges.Methods. A total of 8,261 newborns underwent simultaneous NBHS and NGS-based genomic screening targeting 46 deafness genes in this prospective study. The subjects’ genotypes were determined, and those with conclusive genetic diagnoses received audiological assessments.Results. Conclusive genetic diagnoses were confirmed in 164 subjects, with 112 carrying variants in GJB2 and MTRNR1 and 52 carrying variants in other deafness genes. Notably, 126 of these subjects passed the NBHS, suggesting that an additional 1.5% (126/8,261) of children at risk for SNHI, who would have been missed by conventional physiological screening, can be identified through targeted genomic screening in the general population. Furthermore, one subject’s father, who carried a COL4A5 variant, and three paternal relatives of another subject carrying an EDNRB variant (previously undiagnosed) were identified with Alport and Waardenburg syndromes, respectively, underscoring the familial benefits of this approach.Conclusion. Targeted genomic sequencing in newborns may serve as a valuable complement to conventional NBHS by identifying children at risk for SNHI and enabling early diagnosis in families with non-syndromic mimics.
- 15 May 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 176, 108597
Machine learning-based longitudinal prediction for GJB2-related sensorineural hearing loss
- 15 May 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 176, 108597
Machine learning-based longitudinal prediction for GJB2-related sensorineural hearing loss
- Open Access
- 7 September 2023
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 25 (11) , 827-837
Genetic Factors Contribute to the Phenotypic Variability in GJB2-Related Hearing Impairment
- 7 September 2023
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 25 (11) , 827-837
Open AccessGenetic Factors Contribute to the Phenotypic Variability in GJB2-Related Hearing Impairment